According to a new report from Intel Market Research, the global Rifapentine market was valued at USD 320 million in 2025 and is projected to reach USD 520 million by 2034, growing at a CAGR of 5.3% during the forecast period. This growth is fueled by rising tuberculosis prevalence, government initiatives for TB eradication programs, and advancements in healthcare infrastructure. What is...